Abstract:
A method and system for formal planning and implementation of network strategies and architectures is disclosed. More specifically, according to an embodiment of the present invention, network services may be conceptually divided into a framework comprising vertical resources and services and horizontal resources and services. This framework may be used to determine a network's existing capabilities as well as to plan for the network's expansion and evolution. According to one embodiment, the vertical resources and services may comprise transport services capability architecture, virtual network capability architecture, security capability service architecture and quality of service architecture. The horizontal resources and services may include IP layered services architecture, core network services architecture and core network transport architecture.
Abstract:
The invention provides systems containing a sterile container for aspiration, filtering, treating and reinjection into a subject of a bodily fluid in a sterile environment. The systems are particularly designed to facilitate transfection of cells within the sterile container by gene therapy molecules and reinjection of the transfected cells into the donor at controlled depth in precisely controlled volumes such as is useful for revascularization of ischemic cardiac tissue. For injection, a pressure actuator, preferably hand-held, applies force to liquids held within the sterile container in precisely controlled increments, thereby expressing liquids through a hollow needle or injection catheter in precisely controlled microvolumes. The invention systems include a hand-held injection device with audible cues that correspond to an operator-selected injection volume and/or audible cues that correspond to needle penetration depth selected by the operator.
Abstract:
Provided are a method, article of manufacture, and apparatus for estimating delays of networks. An automated design system comprises a computer configured to identify a critical path in a network, calculate a delay for the technology-mapped version of the network, calculate a delay for the technology-independent version of the network, calculate a scale factor from the technology-mapped and technology-independent delays, and apply the scale factor to all the delays in the technology-independent network.
Abstract:
A left atrium ablation catheter (4), including a sheath (8) and a deflectable electrophysiology catheter (10) housed within the sheath, is used to ablate coronary tissue at a target site within the left atrium (LA) of a heart. The electrophysiology catheter has ablation electrodes (24) along the tip (10). The ablation catheter is introduced into the right atrium (RA) through either the superior vena cava (SVC) or the inferior vena cava (IVC). The distal open end of the sheath is guided through a punctured hole in the interatrial septum and into the left atrium. The distal end (20) of the sheath is either precurved or is steerable so the electrode tip can be directed to the coronary target site in the left atrium. The electrode tip is sized and configured to create the desired lesion at the target site without movement of the electrode tip.
Abstract:
An electronic chassis and filter apparatus is provided. A chassis includes a top portion, a bottom portion, a first side wall portion, and a second side wall portion. The bottom portion includes an open front side, a closed back side, a first guide rail portion and a second guide rail portion. An ejector spring is operatively attached to the back side of the bottom portion, and a spring-biased actuator is operatively connected to the first rail portion adjacent the open front side. When the filter is inserted into the open front side, the filter contacts the ejector spring which biases the filter against the spring-biased actuator.
Abstract:
A catheter assembly (2) includes a catheter shaft (6) having a tip portion (10) with a hollow interior (30) and a linear ablation electrode (18, 34, 36, 44, 58) spaced apart from the distal end (22) of the tip portion. The electrode has an inner surface (28) which is effectively fluidly exposed to the hollow interior so that a cooling fluid (32) passing through the interior contacts the inner surface so to effectively cool the electrode. The electrode can include a series of band electrodes (18, 34) or one or more spiral electrodes (36, 44, 58). One method for making the tip portion involves mounting the electrode to a mandrel, filling the spaces between the edges (26) of the electrode with a polymer and then removing the resulting tubular structure from the mandrel. The cooling fluid can pass through a hollow spiral electrode (58) for enhanced cooling effectiveness.
Abstract:
A suture sleeve for anchoring the lead body of an implantable medical device is fabricated of a biocompatible, polymeric material to which has been added color pigment in clear contrast with the bodily tissue adjacent the sleeve. The sleeve is therefore readily visible to the naked eye to aid the physician in locating the sleeve during lead implant or lead revision. Furthermore, the tubular body may be radiopaque and, therefore, easily seen on a fluoroscope through the addition of a radiologically dense material, such as tantalum powder, to the plastic from which the sleeve is molded.
Abstract:
An electrical conductor assembly utilized, for example, in a defibrillator patch lead to interconnect a pulse generator and monitoring unit, and a wire mesh electrode pad. The electrical conductor includes a Teflon insulated drawn brazed stranded (DBS) wire cable which is wrapped in a drawn filled tube (DFT) wire multifilar coil encased in a biocompatible insulative tubing.
Abstract:
Disclosed are a traditional Chinese medicine composition and a traditional Chinese medicine extract composition for treating metabolic syndrome. The traditional Chinese medicine composition consists of the following raw materials in the following weight ratio: 5-80% of Coptidis Rhizoma, 5-70% of Aurantii Fructus Immaturus, 0-60% of Pinelliae Rhizoma, 0-40% of Trichosanthis Fructus, 0-12% of Cinnamomi Cortex, and 10-60% of red yeast rice. The traditional Chinese medicine extract composition consists of the following raw materials in the following weight ratio: 2-30% of Coptidis Rhizoma extract, and 70-98% of a mixed extract from five traditional Chinese medicines comprising Aurantii Fructus Immaturus, Pinelliae Rhizoma, red yeast rice, Trichosanthis Fructus, and Cinnamomi Cortex. The traditional Chinese medicine composition or the traditional Chinese medicine extract composition contains the following active ingredients (mg/g): 6-122 mg/g of total alkaloids, which comprises 4-89 mg/g of berberine, 30-315 mg/g of total flavonoids, which comprises 20-186 mg/g of neohesperidin: and 0.5-9 mg/g of lovastatin. Further provided are preparation methods and applications of the above compositions.
Abstract:
A printer is described. The printer includes a processor. A memory is coupled to the processor. The memory contains instructions that when processed by the processor cause a method to be performed. The method includes presenting a list of printing substitutions on a display. The printing substitutions are each associated with a respective printer profile. The list of printing substitutions identify which ones of the printing substitutions are enabled and which ones of the printing substitutions are disabled. The list also identifies the printer profiles that the substitutions are associated with, wherein at least one printer profile that is not enabled for a current print job is included in the list.